U.S. President Donald Trump spoke with Pfizer CEO Ian Read to say that the company’s July 1 price increases had complicated the administrations drug pricing plans, prompting the drug maker to defer its planned hikes, Reuters reports, citing a source familiar with the matter. Pfizer said Tuesday it was deferring its drug price hikes for no more than six months following Read’s phone call with the president, the report notes. U.S. Health and Human Services secretary Alex Azar called the Pfizer CEO previously, but Read asked to speak directly with Trump, the report says, citing the source.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.